Conversely, decreased levels of IL‐2 and elevated concentrations of soluble IL‐2 receptors have been detected in end‐stage NSCLC, and this has been linked to unfavourable outcomes.100. The gene discussed is IL2; the disease is non-small cell lung carcinoma.